You have no items in your shopping cart.
Validation & Specificity Standards
Knockdown Validated Antibodies
Ensuring absolute antibody target specificity and experimental reproducibility using genetic RNAi controls.
Knockdown-validated antibodies are essential tools for ensuring specific, accurate detection of target proteins across biological and biomedical research applications. They are especially critical in experiments where antibody cross-reactivity or off-target binding could compromise data integrity.
Antibody manufacturers like Biorbyt perform negative control validation using RNA interference (RNAi). This technique introduces small interfering RNA (siRNA) or short hairpin RNA (shRNA) into target cells to genetically silence the expression of the gene encoding the target protein, "knocking down" its translation.
When evaluated by Western Blot or Immunohistochemistry (IHC), a specific antibody should yield a significantly reduced (or completely absent) signal in the siRNA-treated sample compared to control cells. Achieving this expected loss-of-signal confirms target specificity and ensures high experimental reproducibility under test conditions.
Gold Standard Negative Control
Knockdown validation aligns with international antibody validation guidelines (e.g., the 5 Pillars of Antibody Validation), serving as a definitive genetic control to distinguish true antigen binding from non-specific background.
1. Benefits of Knockdown Validated Antibodies
Utilizing pre-validated knockdown antibodies in your experimental workflow provides several distinct advantages:
- Promotes Experimental Reproducibility: Confirms that observed bands or cellular staining reflect genuine target protein levels rather than off-target binding.
- Reduces Background Noise: Pre-screened clones minimize off-target cross-reactivity, delivering high signal-to-noise ratios.
- Maximizes Data Confidence: Essential for publishing in high-impact journals that require rigorous genetic antibody validation controls.
- Saves Valuable Samples and Reagents: Eliminates wasted tissue samples, reagents, and time spent troubleshooting non-specific antibodies.
2. Overcoming Technical Implementation Challenges
While siRNA knockdown is a gold-standard validation method, establishing RNAi transfection protocols in-house is time-consuming, expensive, and technically demanding. Optimizing transfection efficiency, avoiding off-target siRNA effects, and maintaining cell viability add significant delay to research timelines.
Purchasing pre-validated knockdown antibodies directly from Biorbyt allows researchers to commence experiments immediately, confident that the antibody has already been genetically verified. This saves time and resources while eliminating the potential errors associated with in-house siRNA knockdown experiments.
3. Popular Knockdown Validated Antibodies
Browse Biorbyt's top-selling primary antibodies validated via genetic knockdown testing:
Need Guidance on Knockdown Validated Antibodies?
Biorbyt's scientific support team can help you identify pre-validated antibodies or select appropriate positive and negative controls for your research targets.
Contact Scientific Support